Pinealon vs Selank
Research Verdict
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
Quick Answers
Which is better, Pinealon or Selank?
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
What is the key difference between Pinealon and Selank?
Selank is a tuftsin-derived heptapeptide with characterized GABA/serotonin modulation; pinealon is a synthetic tripeptide from Khavinson bioregulation theory with no independently validated mechanism.
Evidence Comparison
Selank: Russian RCT data (Semenova 2010, n=38), approved anxiolytic. Pinealon: Khavinson tripeptide (Glu-Asp-Arg) with claims of CNS-protective effects based on single-group studies without independent replication. Selank is categorically stronger.
Evidence Context Favoring Pinealon
Only in the specific context of Khavinson bioregulator research - no evidence supports pinealon over selank.
Evidence Context Favoring Selank
Any anxiolytic or neuroprotective research context; selank has the published clinical evidence.
Side-by-Side Snapshot
| Evidence grade | Pinealon: Level D Selank: Level C |
|---|---|
| Research status | Pinealon: Early Research Selank: Approved Outside US |
| Primary category | Pinealon: Cognitive & Nootropic Selank: Cognitive & Nootropic |
| Cited studies | Pinealon: 2 Selank: 2 |